title: Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?
abstract: In this opinion statement, we give a critical synopsis of the state-of-the-art of bioinformatic HIV resistance analysis and point out what we consider to be challenges and perspectives.
authors.affiliation: Max Planck Institute for Informatics, Saarbrücken, Germany. lengauer@mpi-inf.mpg.de
authors.forename: Thomas
authors.initials: T
authors.lastname: Lengauer
mesh_terms: D019295:Computational Biology / Q000379:methods*; D024882:Drug Resistance, Viral; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods*; D058889:Molecular Typing / Q000379:methods*